Gene Panel ALL Risk Stratification - T-ALL

Also known as: Gene panel ALL risk stratification - T-ALL**

50+ booked in last 3 days

No special precautions

Sample Type

Blood

Recommended for

Male, Female

Report

Within 24 Hours

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

T cells, also known as T lymphocytes, are a type of white blood cell that plays a crucial role in the immune system. They are responsible for recognising foreign substances and triggering an immune response to destroy them. The Gene panel ALL risk stratification - T-ALL test is a diagnostic tool used to assess T-cell acute lymphoblastic leukemia (T-ALL) and perform risk stratification based on genetic analysis. By analyzing specific genes associated with T-ALL, this panel helps identify molecular markers that can inform healthcare professionals about the disease's aggressiveness and potential treatment response. The results from this gene panel aid in categorizing patients into different risk groups, allowing for personalized treatment plans and improved prognostic predictions.

Gene panel ALL risk stratification - T-ALL** Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Gene panel ALL risk stratification - T-ALL** with a clear pricing structure.

The Gene panel ALL risk stratification - T-ALL** Price in Mumbai is ₹ 17,850 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

What does Gene Panel - T ALL measure?

Gene Panel - T ALL detects specific genes associated with risk stratification of T-cell acute lymphoblastic leukaemia (T-ALL).

Why is Gene Panel - T ALL done?

• To diagnose T-cell acute lymphoblastic leukaemia (T-ALL) • To identify specific genetic mutations or abnormalities that guide treatment decisions • To assess the risk of disease recurrence or relapse • To monitor treatment response and disease progression

When is Gene Panel - T ALL recommended and who should take the test?

Gene Panel - T ALL is recommended for • individuals with suspected or confirmed T-cell acute lymphoblastic leukaemia (T-ALL), • patients undergoing treatment for T-ALL to monitor response, • individuals with a family history of T-ALL or genetic risk factors for the condition, and • patients with symptoms suggestive of T-ALL, such as fatigue, unexplained weight loss, recurrent infections, or bone pain.

What if the results of the Gene Panel - T ALL are abnormal?

The results of Gene Panel - T ALL may reveal various genetic mutations or abnormalities associated with T-cell acute lymphoblastic leukaemia (T-ALL). Abnormal results indicate the presence of these mutations or abnormalities.

What to expect during the Gene Panel - T ALL?

During the test, a small blood sample or bone marrow aspirate will be collected using a needle. The sample will be sent to the laboratory for analysis.

What preparations are required before the Gene Panel - T ALL?

• Provide a detailed genetic history if available. • Inform your healthcare provider about any medications or supplements you are taking as they may impact the interpretation of the test results. Also, tell them if you have any specific requirements.

What other tests may be ordered with Gene Panel - T ALL?

• Complete blood count (CBC): to assess overall blood cell counts • Flow cytometry: to identify specific markers on the surface of leukaemia cells • Bone marrow biopsy: to evaluate cell morphology and distribution in the bone marrow

What is the Gene Panel - T ALL also known as?

T-cell acute lymphoblastic leukaemia genetic testing

What is T-cell acute lymphoblastic leukaemia (T-ALL)?

T-cell acute lymphoblastic leukaemia is a type of blood cancer that affects the development of T cells, a type of white blood cell. It leads to an overproduction of immature lymphoblasts in the bone marrow and bloodstream, interfering with normal blood cell production and function. T-ALL is more common in children and adolescents.

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.